Hologic (HOLX) Tops Q4 EPS by 85c; Guides Above Views

Hologic (NASDAQ: HOLX) reported Q4 EPS of $2.07, $0.85 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.12 billion.

“We capped off an unprecedented fiscal year with remarkable financial results in our fourth quarter,” said Steve MacMillan, Hologic’s Chairman, President and Chief Executive Officer. “These results were driven by the tireless efforts of our Diagnostics, European and supply chain teams to provide COVID-19 tests, and by steady improvement in our other businesses compared to the June quarter.”

GUIDANCE:

Hologic sees Q1 2021 EPS of $2.10-$2.25, versus the consensus of $1.23. Hologic sees Q1 2021 revenue of $1.35-1.425 billion, versus the consensus of $1.13 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Oracle’s Ellison cancels plan to sell up to 50 mln shares
• Investing.com’s stocks of the week